Testing effectiveness (Phase 2)Study completedNCT00855218
What this trial is testing
A Phase II Randomized, Double-blind, Placebo-controlled Study of Sorafenib or Placebo in Combination With Transarterial Chemoembolization (TACE) Performed With DC Bead and Doxorubicin for Intermediate Stage Hepatocellular Carcinoma (HCC).
Who this might be right for
Carcinoma, Hepatocellular
Bayer 307